Hani Alotaibi

Dr. Hani Alotaibi

Izmir Biomedicine and Genome Centre
+1
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2019 in Cells
Verified
Journal Article
Open access
PDF file
Burcu SengezBurcu Sengez
Burcu Sengez
IAIlkin Aygün
Ilkin Aygün
HSHuma Shehwana
Huma Shehwana
NTNeslihan Toyran
Neslihan Toyran
SASanem Tercan Avci
Sanem Tercan Avci
HAHani Alotaibi
Hani Alotaibi
The epithelial to mesenchymal transition (EMT) and the mesenchymal to epithelial transition (MET) are two critical biological processes that are involved in both physiological events such as embryogenesis and development and also pathological events such as tumorigenesis. They present with dramatic changes in cellular morphology and gene expression exhibiting acute changes in E-cadherin expression. Despite the comprehensive understanding of EMT, the regulation of MET is far from being understood. To find novel regulators of MET, we hypothesized that such factors would correlate with Cdh1 expression. Bioinformatics examination of several expression profiles suggested Elf3 as a strong candidate. Depletion of Elf3 at the onset of MET severely impaired the progression to the epithelial state. This MET defect was explained, in part, by the absence of E-cadherin at the plasma membrane. Moreover, during MET, ELF3 interacts with the Grhl3 promoter and activates its expression. Our findings present novel insights into the regulation of MET and reveal ELF3 as an indispensable guardian of the epithelial state. A better understanding of MET will, eventually, lead to better management of metastatic cancers.

1 June 2015 in Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
Verified
Journal Article
Closed access
HAHani Alotaibi
Hani Alotaibi
MBM. Felicia Basilicata
M. Felicia Basilicata
HSHuma Shehwana
Huma Shehwana
TKTyler Kosowan
Tyler Kosowan
ISIlona Schreck
Ilona Schreck
MSMarc P. Stemmler
Marc P. Stemmler

1 November 2013 in Stem Cell Research
Verified
Journal Article
Closed access
IBIvan Bedzhov
Ivan Bedzhov
HAHani Alotaibi
Hani Alotaibi
MBM. Felicia Basilicata
M. Felicia Basilicata
KAKerstin Ahlborn
Kerstin Ahlborn
ELEwa Liszewska
Ewa Liszewska
MSMarc P. Stemmler
Marc P. Stemmler

12 January 2022 in Journal of Gastrointestinal Cancer
Verified
Journal Article
Closed access
PDF file
Burcu SengezBurcu Sengez
Burcu Sengez
BCBrian Irving Carr
Brian Irving Carr
HAHani Alotaibi
Hani Alotaibi

1 January 2008 in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Verified
Journal Article
Closed access
HAHani Alotaibi
Hani Alotaibi
MRMarie D. Ricciardone
Marie D. Ricciardone
MOMehmet Ozturk
Mehmet Ozturk

29 January 2010 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
HAHani Alotaibi
Hani Alotaibi
EYElif Yaman
Elif Yaman
Domenico SalvatoreDomenico Salvatore
Domenico Salvatore
Valeria Di DatoValeria Di Dato
Valeria Di Dato
Pelin TELKOPARAN AKILLILARPelin TELKOPARAN AKILLILAR
Pelin TELKOPARAN AKILLILAR
UTUygar H. Tazebay
Uygar H. Tazebay
Activity of the sodium/iodide symporter (NIS) in lactating breast is essential for iodide (I–) accumulation in milk. Significant NIS upregulation was also reported in breast cancer, indicating a potential use of radioiodide treatment. All-trans-retinoic acid (tRA) is a potent ligand that enhances NIS expression in a subset of breast cancer cell lines and in experimental breast cancer models. Indirect tRA stimulation of NIS in breast cancer cells is very well documented; however, direct upregulation by tRA-activated nuclear receptors has not been identified yet. Aiming to uncover cis-acting elements directly regulating NIS expression, we screened evolutionary-conserved non-coding genomic sequences for responsiveness to tRA in MCF-7. Here, we report that a potent enhancer in the first intron of NIS mediates direct regulation by tRA-stimulated nuclear receptors. In vitro as well as in vivo DNA–protein interaction assays revealed direct association between retinoic acid receptor-α (RARα) and retinoid-X-receptor (RXR) with this enhancer. Moreover, using chromatin immunoprecipitation (ChIP) we uncovered early events of NIS transcription in response to tRA, which require the interaction of several novel intronic tRA responsive elements. These findings indicate a complex interplay between nuclear receptors, RNA Pol-II and multiple intronic RAREs in NIS gene, and they establish a novel mechanistic model for tRA-induced gene transcription.